Estados Unidos · Revistas de economía · Quartz

Lycia Therapeutics stock surges in IPO debut after pricing about $317.5M offering

Publicado por Quartz · Estados Unidos hace 1 h

The drug developer priced 17.64 million shares at $18 each, and the offering is expected to close on Oct. 26

Leer el artículo completo en Quartz Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (qz.com)

También te puede interesar

PE Hub Lasted 20 Years. Now Its Founder Dan Primack Says the Brand Has ‘Met Its Maker’

Let 17-year-olds change their minds. In the age of AI, it’s their best career move

First Pillsbury and Trader Joe’s. Now another food brand is recalling products over glass concerns

Markets Insider (Business Insider)

Oregon Bancorp GAAP EPS of $0.30, revenue of $4.87M

9 Changes to Social Security in 2027

AI Cybersecurity Risks: What’s Overhyped And What’s Overlooked